11/21/2023
Evangelyn Rodriguez
Chronic myeloid leukemia (CML) is a type of blood cancer that's caused by a genetic change in myeloid cells, the cells in your blood marrow that eventually mature into red blood cells, platelets and white blood cells.
In a clinical trial involving 50 CML patients, researchers found that combining imatinib, a targeted cancer drug commonly used to treat CML, with curcumin supplementation resulted in a far greater decrease in nitric oxide (NO) levels than imatinib treatment alone. Decreasing NO levels benefits CML patients because NO promotes the growth, invasion and metastasis of cancer cells.
-
Tags
#Cancer